Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
Comparative Study of Indigenous Green Laser With Already Available Green Laser in Proliferative Diabetic Retinopathy
1 other identifier
interventional
24
1 country
1
Brief Summary
To Demonstrate that indigenous green laser produces similar treatment effect on the retina when compared with already available green laser.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Dec 2005
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 21, 2006
CompletedFirst Posted
Study publicly available on registry
July 24, 2006
CompletedFebruary 11, 2009
February 1, 2009
7 months
July 21, 2006
February 10, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pigmentation of burn
2 months, 4 months, 6 months post laser
Lateral spread of burn
2 months, 4 months, 6 months post laser
Regression of new vessels
2 months, 4 months, 6 months post laser
Secondary Outcomes (4)
Choroidal detachment
2 months, 4 months, 6 months post laser
Retinal detachment
2 months, 4 months, 6 months post laser
Tractional retinal detachment
2 months, 4 months, 6 months post laser
Bruch's membrane rupture
2 months, 4 months, 6 months post laser
Study Arms (2)
1
EXPERIMENTALAurolab Green Laser
2
ACTIVE COMPARATORAvailable Green Laser
Interventions
Eligibility Criteria
You may qualify if:
- Patients more than 18 years of age
- Eyes with proliferative diabetic retinopathy requiring laser photocoagulation
You may not qualify if:
- Eyes with media opacities not allowing proper fundus photography or adequate laser photocoagulation
- Patients requiring more than two sessions of laser photocoagulation
- Patients who had undergone previous laser photocoagulation
- Patients who had undergone any previous vitreo-retinal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aurolablead
- Raja Ramanna Centre for Advanced Technology (RRCAT)collaborator
Study Sites (1)
Arvind Eye Hospital
Madurai, Tamil Nadu, 625 020, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chandra Mohan, MS
Arvind Eye Hospital, Madurai
- PRINCIPAL INVESTIGATOR
Dhananjay Shukla, MS
Aravind Eye Hospital
- PRINCIPAL INVESTIGATOR
Naresh Babu, MS, FNB
Aravind Eye Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 21, 2006
First Posted
July 24, 2006
Study Start
December 1, 2005
Primary Completion
July 1, 2006
Study Completion
July 1, 2006
Last Updated
February 11, 2009
Record last verified: 2009-02